[1]李国峰,张少利,徐伟强,等.原发性肝癌患者 TGF-β1水平与浸润及转移的关系[J].医学临床研究,2015,32(10):2048-2050. [2]李明,蔡永萍,鲁康洋,等.AT 序列特异性结合蛋白2在骨肉瘤病理诊断中的价值[J].中华病理学杂志,2016,45(9):631-635. [3]陈虎,周培培,杨蓉,等.SATB2、NANOG和OCT4在口腔鳞癌中的表达及临床意义[J].口腔医学,2015,35(12):1016-1019. [4]Mansour MA,Hyodo T,Ito S,et al.SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling[J].Febs J,2015,282(8):1394. [5]Shen Z,Zeng Y,Guo J,et al.Over-expression of the special AT rich sequence binding protein 1 (SATB1) promotes the progression of nasopharyngeal carcinoma:association with EBV LMP-1 expression[J].J Transl Med,2013,11(1):217. [6]张军,马立,李月红,等.卵巢浆液性腺癌BRMS1、RIZ1和SATB1蛋白表达及其与预后的关系[J].临床与实验病理学杂志,2015,31(11):1214-1218. [7]王凤,陈世荣,樊峰,等.结直肠癌组织SATB2蛋白表达与上皮-间充质转化相关性研究[J].中华肿瘤防治杂志,2015,22(19):1540-1543. [8]Wang S,Zhou J,Wang X,et al.Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer[J].J Pathol,2009,219(1):114-122.
2017, Vol. 34 
